Search results for:
hepatitis B adult vaccine
hepatitis B adult vaccine
- Ambulatory: 10mcg/mL - Urgent Care, Women's Wellness
- Ambulatory: 20mcg/0.5mL - Urgent Care, Women's Wellness
- Ambulatory: 20mcg/mL - Dermatology, Internal Medicine, Urgent Care, Women's Wellness
Drug Name |
Form |
Strength |
Infusion Center Available |
Restricted |
Non-formulary |
Ambulatory Available |
Interchange |
REMS |
Heplisav-B |
SOLUTION, INTRAMUSCULAR |
20 mcg/0.5 mL |
|
|
|
|
|
|
Engerix-B |
SUSPENSION, INTRAMUSCULAR |
20 mcg/mL |
|
|
|
|
|
|
Last updated: Dec. 23, 2024
Hepatitis B Vaccine Criteria (as of September 2018):
Recombivax HB (manufacturer: Merck) adult, pediatric, and dialysis formulations are currently unavailable.
Heplisav-B (manufacturer: Dynavax) is the preferred vaccine for:
• Adult (≥ 18 years of age) inpatients, outpatients, and employees who are not pregnant and not receiving dialysis.
• Given as 2-dose series at least 1 month apart.
Engerix-B (manufacturer: Glaxo Smith Kline) is the preferred vaccine for:
• Pediatric patients (< 18 years of age)
• Pregnant patients
• Dialysis patients (use TWO doses of Engerix-B on 4-dose schedule at 0, 1, 2 and 6 months)
• Second-line vaccine option for all adults